Seyon first glimpse: The first glimpse of Sivakumar Murugesan’s Seyon, starring Sivakarthikeyan in the lead role, was released on Tuesday. The glimpse released on Sivakarthikeyan’s birthday shows him ...

The Seattle Seahawks and New England Patriots are set to meet in what should be a thrilling Super Bowl. Given how close the spread is, we could be in for a classic decided in the final moments of ...

The King and Queen for the First Ever 23rd Annual World's Shortest St. Patrick's Day Parade will be the editor-publisher of the city's monthly tourism magazine and the World's Tallest Leprechaun.

Abstract: In recent years, as the demand for computing power in scientific computing has progressively increased, the scale of scientific applications has also grown, at the same time the number of ...

In Coimbatore's Selvapuram neighborhood, where family homes overlook open fields dotted with tall trees, a 1,550-square-foot home taps into the simplicity of Tamil architecture past. Designed by ...

AIADMK General Secretary Edappadi K Palaniswami on Saturday announced the first phase of the party's poll promises for the upcoming Tamil Nadu Legislative Assembly elections. Viscera report solves ...

The global visa wait time data includes both average waiting periods and the estimated date of the next available interview appointment. Updated: Jan 16, 2026 16:54 IST US visa interview waiting time ...

The 2025 College Football Playoff is down to eight teams. The second iteration of the 12-team bracket is off to a booming start, with No. 9 Alabama kicking things off with a thrilling comeback win ...

A second-round draft pick by the Cowboys in 2020, Trevon Diggs was released Tuesday after making six starts in eight games this season. Sam Hodde / Getty Images The Dallas Cowboys released veteran ...

Shortest path algorithms sit at the heart of modern graph theory and many of the systems that move people, data, and goods around the world. After nearly seventy years of relying on the same classic ...

HORSHAM, Pa., Dec. 17, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and ...